Aquapharm and Croda International Sign Three Year Research Collaboration Agreement

Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales CRN Announces New Dues Structure For 2009 The Council for Responsible Nutrition (CRN) has announced a new membership dues structure for Voting members, effective January 2009, in an effort to make membership more accessible to mid-size and even smaller companies in the industry. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Cargill receives patent for breakthrough taste modification ID technology Cargill has announced that it has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better. Cargill receives patent for breakthrough taste modification ID technology Cargill has announced that it has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better. Cargill receives patent for breakthrough taste modification ID technology Cargill has announced that it has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better. Silliker Announces Proprietary Testing Method Licensing Agreement with Kraft Foods Silliker has announced a licensing agreement with Kraft Foods for a patent pending in vitro method for predicting the Glycemic Index (GI) of foods. Silliker Announces Proprietary Testing Method Licensing Agreement with Kraft Foods Silliker has announced a licensing agreement with Kraft Foods for a patent pending in vitro method for predicting the Glycemic Index (GI) of foods. Silliker Announces Proprietary Testing Method Licensing Agreement with Kraft Foods Silliker has announced a licensing agreement with Kraft Foods for a patent pending in vitro method for predicting the Glycemic Index (GI) of foods. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. SunOpta Announces First Quarter 2008 Results SunOpta Inc. (STKL) (CA:SOY) has announced FY08 Q1 results, reporting revenues of $230,444,000 as compared to $183,500,000 in the first quarter of 2007, with earnings of $1,486,000 or $0.02 per diluted common share as compared to 2007 first quarter earnings of $1,055,000 or $0.02 per diluted common share. SunOpta Announces First Quarter 2008 Results SunOpta Inc. (STKL) (CA:SOY) has announced FY08 Q1 results, reporting revenues of $230,444,000 as compared to $183,500,000 in the first quarter of 2007, with earnings of $1,486,000 or $0.02 per diluted common share as compared to 2007 first quarter earnings of $1,055,000 or $0.02 per diluted common share. SunOpta Announces First Quarter 2008 Results SunOpta Inc. (STKL) (CA:SOY) has announced FY08 Q1 results, reporting revenues of $230,444,000 as compared to $183,500,000 in the first quarter of 2007, with earnings of $1,486,000 or $0.02 per diluted common share as compared to 2007 first quarter earnings of $1,055,000 or $0.02 per diluted common share. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Reliv International Reports Second-Quarter Results; Restructures European Operations Reliv International, Inc. (RELV) has announced FY08 Q12 results, reporting net sales of $24.0 million, compared to net sales of $26.3 million in the second quarter last year, with net income of $569,000 or $0.04 per diluted share, compared to net income of $823,000 or $0.05 per diluted share in the second quarter of 2007. Reliv International Reports Second-Quarter Results; Restructures European Operations Reliv International, Inc. (RELV) has announced FY08 Q12 results, reporting net sales of $24.0 million, compared to net sales of $26.3 million in the second quarter last year, with net income of $569,000 or $0.04 per diluted share, compared to net income of $823,000 or $0.05 per diluted share in the second quarter of 2007. Nu Skin Enterprises Reports Second-Quarter 2008 Results Nu Skin Enterprises, Inc. (NUS) has announced FY08 Q2 results, reporting revenue of $321.7 million, a 12 percent improvement over the prior-year period, with earnings per share of $0.32 compared to $0.21 for the same quarter of 2007. Nu Skin Enterprises Reports Second-Quarter 2008 Results Nu Skin Enterprises, Inc. (NUS) has announced FY08 Q2 results, reporting revenue of $321.7 million, a 12 percent improvement over the prior-year period, with earnings per share of $0.32 compared to $0.21 for the same quarter of 2007. Nutraceutical Reports Q3 Results Nutraceutical International Corporation (NUTR) has announced FY08 Q3 results, reporting net sales of $40.5 million compared to $38.7 million for the same quarter prior year, with net income of $2.9 million, or $0.26 diluted earnings per share, compared to net income of $2.9 million, or $0.25 diluted earnings per share, for the same quarter of fiscal 2007. Nutraceutical Reports Q3 Results Nutraceutical International Corporation (NUTR) has announced FY08 Q3 results, reporting net sales of $40.5 million compared to $38.7 million for the same quarter prior year, with net income of $2.9 million, or $0.26 diluted earnings per share, compared to net income of $2.9 million, or $0.25 diluted earnings per share, for the same quarter of fiscal 2007. Balchem Corporation Announces 2nd Quarter 2008 Results Balchem Corporation (BCPC) has announced FY08 Q2 results, reporting net sales of $62.9 million compared to $44.4 million prior year, with net earnings of $4.7 million, an increase of $0.7 million, or 16.2% as compared with the same period last year. Sales of the Food, Pharma and Nutrition segment were $9.5 million, an increase of 19.6% from the prior year comparable quarter. Balchem Corporation Announces 2nd Quarter 2008 Results Balchem Corporation (BCPC) has announced FY08 Q2 results, reporting net sales of $62.9 million compared to $44.4 million prior year, with net earnings of $4.7 million, an increase of $0.7 million, or 16.2% as compared with the same period last year. Sales of the Food, Pharma and Nutrition segment were $9.5 million, an increase of 19.6% from the prior year comparable quarter. PacificHealth Laboratories Reports Second Quarter 2008 Results PacificHealth Laboratories, Inc. (PHLI) has announced Fy08 Q2 results, reporting revenues of $2,370,429 compared to $2,069,889 for the same period in 2007, with a net loss of ($146,608), or ($0.01) per share compared to a net loss of ($127,276), or ($0.01) per share, for the same period in 2007. PacificHealth Laboratories Reports Second Quarter 2008 Results PacificHealth Laboratories, Inc. (PHLI) has announced Fy08 Q2 results, reporting revenues of $2,370,429 compared to $2,069,889 for the same period in 2007, with a net loss of ($146,608), or ($0.01) per share compared to a net loss of ($127,276), or ($0.01) per share, for the same period in 2007. Fenchem Maintains Competitive Vitamin E price The price of Fenchem’s TOCOVET® natural source vitamin E in North America is being maintained within the marketplace, due to large stocks and expanding production. Fenchem Maintains Competitive Vitamin E price The price of Fenchem’s TOCOVET® natural source vitamin E in North America is being maintained within the marketplace, due to large stocks and expanding production. DNP Notches 8% Second Quarter Increase DNP International has reported an eight percent second quarter increase compared to last year during the same time. DNP Notches 8% Second Quarter Increase DNP International has reported an eight percent second quarter increase compared to last year during the same time. Natural Alternatives International, Inc. Announces Sale of 'As We Change(R)' Assets and Provides Fourth Quarter Revenue Update Natural Alternatives International, Inc. (NAII) has announced that it has sold the "As We Change(R)" catalog and internet business of Real Health Laboratories, Inc., its wholly owned subsidiary, for $2.0 million subject to certain adjustments. Natural Alternatives International, Inc. Announces Sale of 'As We Change(R)' Assets and Provides Fourth Quarter Revenue Update Natural Alternatives International, Inc. (NAII) has announced that it has sold the "As We Change(R)" catalog and internet business of Real Health Laboratories, Inc., its wholly owned subsidiary, for $2.0 million subject to certain adjustments. Whole Foods Market reports third quarter results Whole Foods Market, Inc. has announced FY Q3 results reporting sales of approximately $1.8 billion with comparable store sales increased 2.6% Net income was approximately $33.9 million, and diluted earnings per share were $0.24 Whole Foods Market reports third quarter results Whole Foods Market, Inc. has announced FY Q3 results reporting sales of approximately $1.8 billion with comparable store sales increased 2.6% Net income was approximately $33.9 million, and diluted earnings per share were $0.24 Herbalife announces record Q2 results Herbalife Ltd. (HLF) has announced FY08 Q2 results, reporting net sales of $639.7 million, an increase of 20.7 percent compared to the same period of 2007, with net income of $67.1 million, or $1.01 per diluted share, compared to $48.1 million, or $0.65 per diluted share in the second quarter of 2007. Herbalife announces record Q2 results Herbalife Ltd. (HLF) has announced FY08 Q2 results, reporting net sales of $639.7 million, an increase of 20.7 percent compared to the same period of 2007, with net income of $67.1 million, or $1.01 per diluted share, compared to $48.1 million, or $0.65 per diluted share in the second quarter of 2007. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. General Nutrition Centers, Inc. Reports Second Quarter 2008 Financial Results General Nutrition Centers, Inc. has announced FY08Q2 results, with reported revenues of $422.7 million, an 8.5% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 6.3%; Franchise by 8.6%; and Manufacturing/Wholesale by 28.0%. Same store sales improved 4.5% in domestic company-owned stores (including internet sales), and 5.2% in Canadian stores General Nutrition Centers, Inc. Reports Second Quarter 2008 Financial Results General Nutrition Centers, Inc. has announced FY08Q2 results, with reported revenues of $422.7 million, an 8.5% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 6.3%; Franchise by 8.6%; and Manufacturing/Wholesale by 28.0%. Same store sales improved 4.5% in domestic company-owned stores (including internet sales), and 5.2% in Canadian stores Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA). Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced. Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced. Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced. Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced. Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced. Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced. Senomyx Announces Second Quarter 2008 Financial Results Senomyx has announced FY08Q2 results, reporting Q2 revenues of $9.6 million for the six months ended June 30, 2008, compared to $6.8 million for the six months ended June 30, 2007. Senomyx Announces Second Quarter 2008 Financial Results Senomyx has announced FY08Q2 results, reporting Q2 revenues of $9.6 million for the six months ended June 30, 2008, compared to $6.8 million for the six months ended June 30, 2007. ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million. ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million. ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million. Omega Protein Reports Second Quarter Results Omega Protein Corporation has announced FY08Q2 results, reporting a Q2 income of $6.7 million ($0.37 per share) with a net income of $2.5 million ($0.15 per share) for the second quater of the previous year. Omega Protein Reports Second Quarter Results Omega Protein Corporation has announced FY08Q2 results, reporting a Q2 income of $6.7 million ($0.37 per share) with a net income of $2.5 million ($0.15 per share) for the second quater of the previous year. Omega Protein Reports Second Quarter Results Omega Protein Corporation has announced FY08Q2 results, reporting a Q2 income of $6.7 million ($0.37 per share) with a net income of $2.5 million ($0.15 per share) for the second quater of the previous year. NutraCea Announces Second Quarter 2008 Financial Results NutraCea (NTRZ) has announced FY08 Q2 results, reporting net revenues of $10.3 million for the second quarter of 2008, compared to net revenues of $13.0 million for the second quarter of 2007, with a one-time license fee of $5.0 million (non-recurring) without which net revenues for the second quarter 2007 would have been $8,000,000. Net loss for the second quarter of 2008 was $6.1 million, or $(0.04) per share, compared to net income of $2.0 million or $0.01 per share for the same period last year. NutraCea Announces Second Quarter 2008 Financial Results NutraCea (NTRZ) has announced FY08 Q2 results, reporting net revenues of $10.3 million for the second quarter of 2008, compared to net revenues of $13.0 million for the second quarter of 2007, with a one-time license fee of $5.0 million (non-recurring) without which net revenues for the second quarter 2007 would have been $8,000,000. Net loss for the second quarter of 2008 was $6.1 million, or $(0.04) per share, compared to net income of $2.0 million or $0.01 per share for the same period last year. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Oban, Scotland - August 4th 2008 – Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement. The three year collaboration will provide Croda with an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Under the agreement Aquapharm will use its proprietary assays to screen its library of marine microbes for the discovery and generation of novel cosmetic ingredients for skin and hair care applications. In return, Aquapharm will receive funding from Croda to conduct this research along with milestone payments and royalties on commercialisation of any resulting products. Further financial details of the agreement were not disclosed. Dr. Andrew Mearns Spragg, CEO of Aquapharm said, “We are very pleased to have entered into this collaboration with Croda, a leading player in the supply of specialty chemicals into the personal care market. This collaboration further demonstrates our leading position in developing new products from marine organisms and the breath of applications of our library. We look forward to working together with Croda to identify novel and natural cosmetic ingredients from our marine library.” Dr Keith Layden, President, Croda Enterprise Technology added, “The collaboration with Aquapharm is a key part of our strategy in developing novel, sustainable solutions for the personal care industry. We are delighted to be working with the team at Aquapharm and anticipate the relationship will generate significant value for both companies.” -ends- About Aquapharm Biodiscovery Ltd. Aquapharm, founded in 2000, is a leading marine biotechnology company based at the European Centre for Marine Biotechnology in Oban, Scotland. Aquapharm is developing new biologically active products from the untapped biological potential of marine microbes. The company has a substantial collection of marine bacteria & fungi obtained from samples collected from diverse marine habitats, including the arctic and the deep sea. It uses these to develop new biologically active products for pharmaceutical, nutraceutical, personal care and industrial applications. Aquapharm’s patented technology base has the ability to manipulate marine microbial communities to stimulate the development and production of new molecules of pharmaceutical potential. About Croda International Plc A global leader in specialty chemicals, Croda is the name behind some of the world’s biggest brands. Environmentally aware and inspired by nature, the Company is at the cutting edge of a diverse range of markets with over 4,000 employees in 35 countries. Croda’s products are sold mainly to industry, so its name is not widely known to the general public. Nevertheless, Croda plays an important part in the natural cosmetic ingredients market with many cosmetic and toiletry preparations incorporating Croda’s natural-based specialties.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software